DexCom, Inc. (NASDAQ: DXCM ) shares got hammered Sept. 28 when rival Abbott Laboratories (NYSE: ABT ) received FDA approval for its FreeStyle Libre flash glucose monitoring system. Investors see Abbott?s ...